|
Federal
Register Notices > Notices of
Registration - 2007
>
Cambrex North Brunswick, Inc.
FR Doc E7-22468 [Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices] [Page 64676-64677] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-137]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 31, 2007, and published in the Federal Register on
August 9, 2007, (72 FR 44860), Cambrex North Brunswick, Inc., Technology Centre
of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk
[[Page 64677]]
manufacturer of the basic classes of controlled substances listed in schedule
I and II:
|
Drug
|
Schedule
|
|
N-Ethylamphetamine (1475)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Morphine (9300)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Cambrex North
Brunswick, Inc. to manufacture the listed basic classes of controlled substances
is consistent with the public interest at this time. DEA has investigated
Cambrex North Brunswick, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-22468 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
